Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Thomas Lingelbach
Dipal Patel
Franck Grimaud
Frederic Jacotot
Juan Carlos Jaramillo
Peter Bühler
Petra Pesendorfer
Vincent Dequenne
Board:
Anne-Marie Graffin
Kathrin Jansen
James Connolly
James Sulat
Maïlys Ferrère
Shareholding in %:
BlackRock Fund Advisors 1.09
Bpifrance Participations SA /PRIVATE EQUITY/ 6.22
CDC Croissance SA 1.49
Deep Track Capital LP 4.99
Groupe Grimaud La Corbière SA 8.73
Medical Strategy GmbH 1.06
Norges Bank Investment Management 1.03
Pfizer Inc. 6.87
Polar Capital LLP 3.61
The Vanguard Group, Inc. 2.58
Freefloat 62.32
Address: Campus Bio-Ouest, 6, rue Alain Bombard, 44800 Saint-Herblain
T: +33-2-28-07-37-10
F: +
I: http://www.valneva.com
E: info@valneva.com